{"title":"利用可溶性 MHC II 类/肽多聚物检测人类疾病中的抗原特异性 T 细胞。","authors":"Jerome R Bill, Brian L Kotzin","doi":"10.1186/ar417","DOIUrl":null,"url":null,"abstract":"<p><p>Most techniques that identify antigen-specific T cells are dependent on the response of these cells to the relevant antigen in culture. Soluble multimers of MHC molecules, when occupied with the same peptide, will bind selectively to T cells specific for that MHC/peptide complex. Techniques to produce fluorescent MHC class II/peptide multimers have recently been developed. These reagents provide a method to facilitate detection and isolation of antigen-specific CD4+ T cells and they represent a new research tool to study these cells in patients with immune-mediated diseases.</p>","PeriodicalId":93144,"journal":{"name":"Teion kogaku = Cryogenic engineering : [official journal of the Cryogenic Association of Japan]","volume":"36 1","pages":"261-5"},"PeriodicalIF":0.0000,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128933/pdf/","citationCount":"0","resultStr":"{\"title\":\"Use of soluble MHC class II/peptide multimers to detect antigen-specific T cells in human disease.\",\"authors\":\"Jerome R Bill, Brian L Kotzin\",\"doi\":\"10.1186/ar417\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Most techniques that identify antigen-specific T cells are dependent on the response of these cells to the relevant antigen in culture. Soluble multimers of MHC molecules, when occupied with the same peptide, will bind selectively to T cells specific for that MHC/peptide complex. Techniques to produce fluorescent MHC class II/peptide multimers have recently been developed. These reagents provide a method to facilitate detection and isolation of antigen-specific CD4+ T cells and they represent a new research tool to study these cells in patients with immune-mediated diseases.</p>\",\"PeriodicalId\":93144,\"journal\":{\"name\":\"Teion kogaku = Cryogenic engineering : [official journal of the Cryogenic Association of Japan]\",\"volume\":\"36 1\",\"pages\":\"261-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128933/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Teion kogaku = Cryogenic engineering : [official journal of the Cryogenic Association of Japan]\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/ar417\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2002/2/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Teion kogaku = Cryogenic engineering : [official journal of the Cryogenic Association of Japan]","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/ar417","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2002/2/28 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
大多数识别抗原特异性 T 细胞的技术都依赖于这些细胞在培养过程中对相关抗原的反应。当 MHC 分子的可溶性多聚体与相同的肽结合时,会选择性地与该 MHC/肽复合物特异性的 T 细胞结合。最近开发出了生产荧光 MHC II 类/肽多聚体的技术。这些试剂提供了一种便于检测和分离抗原特异性 CD4+ T 细胞的方法,是研究免疫介导疾病患者体内这些细胞的一种新的研究工具。
Use of soluble MHC class II/peptide multimers to detect antigen-specific T cells in human disease.
Most techniques that identify antigen-specific T cells are dependent on the response of these cells to the relevant antigen in culture. Soluble multimers of MHC molecules, when occupied with the same peptide, will bind selectively to T cells specific for that MHC/peptide complex. Techniques to produce fluorescent MHC class II/peptide multimers have recently been developed. These reagents provide a method to facilitate detection and isolation of antigen-specific CD4+ T cells and they represent a new research tool to study these cells in patients with immune-mediated diseases.